ReviewRSC advances2025
Exploring the role of strontium-based nanoparticles in modulating bone regeneration and antimicrobial resistance: a public health perspective.
Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Metal-Substituted Hydroxyapatite Nanoparticles as Antimicrobial and Osteogenic Biomaterials for Hard-Tissue Applications.Materials (Basel, Switzerland) · 2026Review
- Article
- Strontium-Functionalized Biomaterials for Bone Regeneration: Mechanisms, Biological Functions, and Clinical Translational Progress.International journal of nanomedicine · 2026Review
- Advances in functional nanomaterials and piezoelectric biomaterials for personalized intramedullary fixation: addressing age-related orthopedic challenges.Frontiers in chemistry · 2026Review
- Injectable hydrogels for bone regeneration: mechanical reinforcement strategies using nanoparticles and nanofibers.ADMET & DMPK · 2026Review
- Collagen-Composite Scaffolds for Alveolar Bone and Dental Tissue Regeneration: Advances in Material Development and Clinical Applications-A Narrative Review.Dentistry journal · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Strontium-based nanoparticles (SrNPs) have emerged as a versatile and promising class of nanomaterials with a wide range of potential applications in healthcare, particularly in the fields of bone regeneration and combating antimicrobial resistance (AMR). Recent research has highlighted the unique properties of SrNPs, including their ability to promote osteogenesis, enhance bone healing, and exhibit strong antimicrobial activity against multidrug-resistant pathogens. These attributes position SrNPs as innovative therapeutic agents with the potential to address challenges such as osteoporosis, bone infections, and the growing global AMR crisis. This comprehensive review critically examines the dual functional potential of SrNPs by analyzing their synthesis methods, physicochemical properties, biological interactions, and translational applications in orthopedic and antimicrobial therapies. Specifically, the review emphasizes SrNPs' ability to enhance bone density, accelerate fracture healing, and reduce the economic burden associated with prolonged treatment and rehabilitation for bone-related diseases. Furthermore, their novel application as antimicrobial agents is explored, highlighting their ability to target bacterial metabolic pathways and combat the rise of antibiotic resistance. The review focuses on the synthesis methods used for SrNPs, particularly co-precipitation, hydrothermal synthesis, and sol-gel techniques. Each method is explored for its ability to produce SrNPs with controlled size, shape, and functionality, while addressing their scalability, cost-effectiveness, and environmental impact. Additionally, the toxicological risks associated with SrNPs are also explored, emphasizing the need for comprehensive preclinical and clinical evaluations to ensure safety for humans and ecosystems. The regulatory and ethical landscape of SrNPs highlights the need for global safety protocols, equitable access, and international cooperation to ensure ethical nanotechnology use. Environmental fate studies address bioaccumulation risks and ecological concerns. This review identifies opportunities and challenges in advancing bone regenerative medicine and combating AMR while emphasizing sustainable and ethical SrNP development for researchers, policymakers, and stakeholders.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.